AIM ImmunoTech annual gross margin
2009
2010
2011
2012
2013
2014
2022
2023
2024
2025
AIM ImmunoTech Gross Margin Growth & History (AIM)
AIM ImmunoTech's gross margin was −45.45% for fiscal 2025.
View full AIM ImmunoTech company overviewAIM ImmunoTech annual gross margin history
| Fiscal year | Period ended | Gross margin | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | −45.45% | −127.22 pp |
| 2024 | 2024-12-31 | 81.76% | +2.56 pp |
| 2023 | 2023-12-31 | 79.21% | −20.79 pp |
| 2022 | 2022-12-31 | 100.00% | — |
| 2014 | 2014-12-31 | −535.03% | +187.64 pp |
| 2013 | 2013-12-31 | −722.67% | +111.14 pp |
| 2012 | 2012-12-31 | −833.80% | −285.98 pp |
| 2011 | 2011-12-31 | −547.83% | +345.51 pp |
| 2010 | 2010-12-31 | −893.33% | −467.21 pp |
| 2009 | 2009-12-31 | −426.13% | — |
AIM ImmunoTech quarterly gross margin
Q2.10
Q3.10
Q1.11
Q2.11
Q3.11
Q4.11
Q1.12
Q2.12
Q3.12
Q4.12
Q1.13
Q2.13
Q3.13
Q4.13
Q1.14
Q2.14
Q3.14
Q4.14
Q1.15
Q2.15
Q3.15
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
| Fiscal quarter | Period ended | Gross margin | Change (percentage points) |
|---|---|---|---|
| Q1 2026 | 2026-03-31 | 81.82% | +44.32 pp |
| Q4 2025 | 2025-12-31 | −90.48% | — |
| Q3 2025 | 2025-09-30 | −161.54% | — |
| Q2 2025 | 2025-06-30 | 60.00% | — |
| Q1 2025 | 2025-03-31 | 37.50% | — |
| Q3 2015 | 2015-09-30 | −1,434.78% | −854.78 pp |
| Q2 2015 | 2015-06-30 | −978.72% | −262.06 pp |
| Q1 2015 | 2015-03-31 | −933.33% | −608.33 pp |
| Q4 2014 | 2014-12-31 | −720.00% | −386.67 pp |
| Q3 2014 | 2014-09-30 | −580.00% | +20.00 pp |
| Q2 2014 | 2014-06-30 | −716.67% | +947.22 pp |
| Q1 2014 | 2014-03-31 | −325.00% | +29.76 pp |
| Q4 2013 | 2013-12-31 | −333.33% | +534.59 pp |
| Q3 2013 | 2013-09-30 | −600.00% | +1833.33 pp |
| Q2 2013 | 2013-06-30 | −1,663.89% | −1339.40 pp |
| Q1 2013 | 2013-03-31 | −354.76% | −65.87 pp |
| Q4 2012 | 2012-12-31 | −867.92% | +161.02 pp |
| Q3 2012 | 2012-09-30 | −2,433.33% | −2051.11 pp |
| Q2 2012 | 2012-06-30 | −324.49% | +142.18 pp |
| Q1 2012 | 2012-03-31 | −288.89% | +70.63 pp |
| Q4 2011 | 2011-12-31 | −1,028.95% | — |
| Q3 2011 | 2011-09-30 | −382.22% | +34.92 pp |
| Q2 2011 | 2011-06-30 | −466.67% | +233.33 pp |
| Q1 2011 | 2011-03-31 | −359.52% | — |
| Q3 2010 | 2010-09-30 | −417.14% | — |
| Q2 2010 | 2010-06-30 | −700.00% | — |
AIM ImmunoTech gross margin trends
Between the periods ended 2009-12-31 and 2025-12-31, AIM ImmunoTech's gross margin increased from −426.13% to −45.45%, a change of +380.67 percentage points. The latest reported quarter, Q1 2026, shows 81.82%.
About the metric
What gross margin means
Gross margin measures the percentage of revenue remaining after the direct costs of producing goods or services. It helps show how efficiently a company turns sales into gross profit before operating expenses.
Calculation and source
How gross margin is calculated
TickerStat calculates gross margin as SEC-reported gross profit divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review AIM ImmunoTech source filings ↗